The association of α-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study

详细信息	查看全文 | 推荐本文 |

• 作者：Laura J. Rasmussen-Torvik ; Mary Cushman ; Michael Y. Tsai ; Yan Zhang ; Susan R. Heckbert ; Wayne D. Rosamond ; Aaron R. Folsom
• 关键词：Deep vein thrombosis ; Fibrinogen ; Polymorphism
• 刊名：Thrombosis Research
• 出版年：2007
• 期刊代码：247_00493848
• 类别：med
• 出版时间：2007
• 卷：121
• 期：1
• 页码：1-7
• 文件大小：132 K

摘要

The α-fibrinogen Thr312Ala variant has been shown to influence clot structure through increased factor XIII cross-linking and formation of thicker fibrin fibers. However, the effect of this common variant on risk of venous thromboembolism (VTE) is unclear. This paper reports the association between the Thr312Ala variant and VTE in the LITE study.

Materials and methods

506 cases and 1014 controls frequency matched on age, sex, race, and study were drawn from two prospective studies and included in the analysis. Logistic regression was used to examine the association between Thr312Ala and VTE.

Results

In a logistic regression model minimally adjusted for the matching variables, the Thr312Ala TA and AA genotypes were associated with a significantly higher risk of VTE than the TT genotype (TA OR and 95%confidence interval 1.27 [1.01–1.60], AA OR 1.49 [1.00–2.22]). Associations were similar in analyses of PE and DVT considered separately and across racial and study subgroups. The association between α-fibrinogen Thr312Ala and VTE was modified by both BMI and the FXIII Val34Leu variant; the combination of elevated BMI or FXIII Val34Leu with α-fibrinogen Thr312Ala conveyed lower odds of VTE than would be expected by an additive or multiplicative model of individual risk factors.

Conclusions

These results suggest that α-fibrinogen Thr312Ala is involved in the pathogenesis of VTE and that its action may be modified by other VTE risk factors.